| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/27/2006 | CA2580913A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1648881A1 Substituted indole ligands for the orl-1 receptor |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | EP1648867A1 Ppar active compounds |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648446A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648444A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648426A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP1313509B1 Treatment of tumors with acetylenes disubstituted with an heteroaromatic group and a substituted thiochromanyl group in combination with other anti-tumor agents |
| 04/26/2006 | CN1764659A Prostaglandin analogs as EP4 receptor antagonists |
| 04/26/2006 | CN1764658A Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764649A Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764635A carboxylic acid compounds |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1764380A N-phenyl- (4-pyridyl)- azinyl!amine derivatives as plant protection agents. |
| 04/26/2006 | CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034051 Fused bicyclic carboxamide derivatives and methods of their use |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034044 NMDA (N-methyl-D- aspartate)-receptor subtype blockers and are used in the treatment or prevention of CNS disorders i.e. Alzheimer's, Parkinson's, etc. |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7033727 Photosensitive composition and acid generator |
| 04/25/2006 | CA2167291C Substituted 2-phenylpyridines with herbicidal action |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006041872A2 Thrombin receptor antagonists |
| 04/20/2006 | WO2006041405A1 Substituted amino-pyrimidones and uses thereof |
| 04/20/2006 | WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1 |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 04/20/2006 | WO2006040176A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040113A2 Heterocyclic diamide insecticidal agents |
| 04/20/2006 | WO2006025979A9 Modulators of nuclear receptors |
| 04/20/2006 | WO2006020156A3 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 04/20/2006 | WO2006019497A3 Sleep-inducing compounds and methods related thereto |
| 04/20/2006 | WO2006013393A3 Quinoline derivatives as neurokinin receptor antagonists |
| 04/20/2006 | WO2005040155A8 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583333A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583096A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | CA2582639A1 Thrombin receptor antagonists |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | CA2580419A1 Novel insecticides |
| 04/19/2006 | EP1646624A1 Indoles useful in the treatment of inflammation |
| 04/19/2006 | EP1646616A2 Combretastatin derivatives with cytotoxic action |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1646613A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 04/19/2006 | EP1646382A2 Compounds, compositions and methods |
| 04/19/2006 | EP1556371B1 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | EP0859772B1 Herbicidal substituted pyridine compounds |
| 04/19/2006 | CN1761657A EP4 receptor antagonists |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/18/2006 | US7030241 Mesylates of piperazine derivatives and process for their preparation |
| 04/18/2006 | US7030153 Including methylsulfonyl attachment, treating arthritis, with analgesic activity without erosion of the stomach, side effect reduction |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030137 Substituted thiophenes with antibacterial activity |
| 04/18/2006 | US7030130 Benzofuran derivatives and their use as antibacterial agents |
| 04/18/2006 | US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/18/2006 | US7029606 Hyperpolarizable organic chromophores |
| 04/14/2006 | WO2005032544A1 Treatment of mitochondrial diseases |
| 04/14/2006 | CA2580584A1 Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| 04/13/2006 | WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |